RXMD - InvestorNewsBreak - Progressive Care Inc.'s (RXMD) PharmcoRx Collaborates to Expand Medicare Advantage OTC Benefits
Progressive Care (OTCQB: RXMD), a personalized health care services and technology provider, today announced that its PharmcoRx pharmacy subsidiary entered an agreement with ProHealth Connect LLC, aiming to extend over-the-counter product (“OTC”) benefits provided by health insurance plans to qualifying members nationwide. Under the partnership, the OTC benefits offered by Medicare Advantage (“MA”) plans such as United, Humana, Devoted, Sharecare, and more, enabling their members to purchase OTC health care products and medicines using their plan benefits, are now accepted at all PharmcoRx pharmacies. “We are thrilled to further expand the access to valuable OTC benefits for our pharmacy customers, enabling them to purchase their over-the-counter products and medications from us when they have their prescriptions filled,” said Dr. Pamela Roberts, chief operating officer of Progressive Care. “Through our participation in these valuable OTC benefit programs, we have the potential to expand awareness of PharmcoRx pharmacies and further serve the needs of millions of Medicare Advantage members as part of our ongoing commitment to community-centric services.”
To view the full press release, visit https://ibn.fm/vfCnV
About Progressive Care Inc.
Progressive Care, through its subsidiaries, is a Florida health services organization and provider of third-party administration (“TPA”), data management, COVID-19-related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (“MTM”), the supply of prescription medications to long-term care facilities, and health practice risk management. Progressive Care became a subsidiary of NextPlat Corp.(NASDAQ: NXPL, NXPLW) on July 1, 2023.
NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at http://ibn.fm/RXMD
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN